3. Pathological staging of Alzheimer’s disease and progression of neurofibrillary pathology and its importance in Alzheimer’s compared with beta-amyloid pathology (1990 – 2001)

Bondareff W, Harrington C, Wischik CM, et al. (1994) Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease. J Neuropathol Exp Neurol 53:158-164.

View abstract

Bondareff W, Wischik CM, Novak M, et al. (1990) Molecular analysis of neurofibrillary degeneration in Alzheimer's disease: an immunohistochemical study. Am J Pathol 137:711-723.

View abstract

Garcia-Sierra F, Hauw JJ, Duyckaerts C, et al. (2000) The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old. Acta Neuropathologica 100:29-35.

View abstract

García-Sierra F, Wischik CM, Harrington CR, et al. (2001) Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer’s disease. J Chem Neuroanat 22:65-77.

View abstract